Home LiteratureArticle Details
PMID: 1612748 Published · ppublish English Comparative Study Journal Article

Interleukin-8 in sepsis: relation to shock and inflammatory mediators.

Infection and immunity ·Vol. 60 ·No. 7 ·1992-07-00 ·Pages 2835-42

Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG, Aarden LA

Abstract

Because of its neutrophil-activating properties, interleukin-8 (IL-8) may play an important role in the pathophysiology of sepsis. We measured circulating IL-8 levels in 47 patients with clinical sepsis. Levels on admission were elevated in 42 of the 47 patients (89%) and were comparable in patients with gram-positive or gram-negative infections. Patients with shock had significantly higher IL-8 levels than normotensive patients (P = 0.0014, Wilcoxon-Mann-Whitney test), whereas no differences in IL-8 levels were found between patients with or without adult respiratory distress syndrome. Patients who died had higher IL-8 levels on admission than the patients who survived. The largest differences in IL-8 levels between survivors and nonsurvivors was found when only patients with positive cultures were considered (P = 0.0342). IL-8 levels appeared to correlate significantly with lactate levels and inversely with leukocyte and platelet numbers and mean arterial pressure. In addition, the IL-8 level in the sepsis patients was found to correlate significantly with levels of IL-6, elastase-alpha 1-antitrypsin, and C3a. Serial observations revealed that in most patients IL-8 levels decreased, irrespective of the outcome. Thus, our results demonstrate that IL-8 levels are increased in most patients with sepsis and correlate with some important clinical, biochemical, and inflammatory parameters. These findings suggest a role for IL-8 in the pathophysiology of sepsis.

MeSH Terms
Adolescent Adult Aged Aged, 80 and over Bacteremia/immunology,mortality Blood Pressure Complement C3a/biosynthesis Enzyme-Linked Immunosorbent Assay Factor XII/analysis Gram-Negative Bacterial Infections/immunology Gram-Positive Bacterial Infections/immunology Humans Interleukin-6/blood Interleukin-8/blood Lactates/blood Lactic Acid Lactoferrin/blood Leukocyte Elastase Middle Aged Pancreatic Elastase/analysis Prekallikrein/analysis Respiratory Distress Syndrome/blood Shock, Septic/immunology,mortality alpha 1-Antitrypsin/analysis
Chemicals
Interleukin-6 Interleukin-8 Lactates alpha 1-Antitrypsin alpha 1-antitrypsin-leukocyte elastase complex Lactic Acid Complement C3a Factor XII Prekallikrein Lactoferrin Pancreatic Elastase Leukocyte Elastase
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Hack C E
Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam.
Hart M
van Schijndel R J
Eerenberg A J
Nuijens J H
Thijs L G
Aarden L A
References (54)
54 references, click to expand
  1. Cachectin: more than a tumor necrosis factor.
    N Engl J Med. 1987 Feb 12;316(7):379-85 PMID: 3543677
  2. The effects of bacterial endotoxins on host mediation systems. A review.
    Am J Pathol. 1978 Nov;93(2):526-618 PMID: 362943
  3. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.
    Surg Gynecol Obstet. 1987 May;164(5):415-22 PMID: 3576418
  4. Shock and tissue injury induced by recombinant human cachectin.
    Science. 1986 Oct 24;234(4775):470-4 PMID: 3764421
  5. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
    Science. 1985 Aug 30;229(4716):869-71 PMID: 3895437
  6. Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutants.
    J Immunol. 1990 Jul 15;145(2):561-8 PMID: 1694882
  7. Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice.
    J Exp Med. 1990 Jun 1;171(6):1853-69 PMID: 2112583
  8. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy.
    Ann Intern Med. 1990 Aug 1;113(3):227-42 PMID: 2197912
  9. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.
    J Lab Clin Med. 1992 Feb;119(2):159-68 PMID: 1740629
  10. Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model.
    J Infect Dis. 1991 Aug;164(2):383-8 PMID: 1906912
  11. Quantification of functional and inactivated alpha 2-macroglobulin in sepsis.
    Thromb Haemost. 1991 Jan 23;65(1):32-9 PMID: 1708920
  12. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.
    Blood. 1990 Dec 15;76(12):2520-6 PMID: 2124934
  13. Fibrinolytic response to tumor necrosis factor in healthy subjects.
    J Exp Med. 1991 Sep 1;174(3):729-32 PMID: 1714936
  14. Regulation of transendothelial neutrophil migration by endogenous interleukin-8.
    Science. 1991 Oct 4;254(5028):99-102 PMID: 1718038
  15. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation.
    J Immunol. 1991 Aug 1;147(3):883-92 PMID: 1650387
  16. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice.
    J Exp Med. 1991 Apr 1;173(4):1029-32 PMID: 1826127
  17. The sequential generation of neutrophil chemoattractant proteins in acute inflammation in the rabbit in vivo. Relationship between C5a and proteins with the characteristics of IL-8/neutrophil-activating protein 1.
    J Immunol. 1991 Jan 15;146(2):677-84 PMID: 1898960
  18. The pathogenesis of sepsis.
    Ann Intern Med. 1991 Sep 15;115(6):457-69 PMID: 1872494
  19. IL-8 in septic shock, endotoxemia, and after IL-1 administration.
    J Immunol. 1991 May 15;146(10):3478-82 PMID: 2026876
  20. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera.
    J Immunol Methods. 1991 Apr 8;138(1):47-56 PMID: 2019746
  21. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents.
    J Exp Med. 1991 Apr 1;173(4):1021-4 PMID: 2007851
  22. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.
    Nature. 1990 Dec 6;348(6301):550-2 PMID: 2147233
  23. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.
    J Immunol. 1990 Dec 15;145(12):4185-91 PMID: 2124237
  24. The role of IFN-gamma in the pathology of experimental endotoxemia.
    J Immunol. 1990 Nov 1;145(9):2920-4 PMID: 2120341
  25. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects.
    N Engl J Med. 1989 May 4;320(18):1165-72 PMID: 2496309
  26. Proteolytic inactivation of plasma C1- inhibitor in sepsis.
    J Clin Invest. 1989 Aug;84(2):443-50 PMID: 2668333
  27. Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis.
    Blood. 1988 Dec;72(6):1841-8 PMID: 3264190
  28. A peptide from alveolar macrophages that releases neutrophil enzymes into the lungs in patients with the adult respiratory distress syndrome.
    Am Rev Respir Dis. 1988 May;137(5):1151-8 PMID: 2848427
  29. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays.
    Thromb Haemost. 1987 Aug 4;58(2):778-85 PMID: 2445044
  30. Novel neutrophil-stimulating peptides.
    Immunol Today. 1989 May;10(5):146-7 PMID: 2663015
  31. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays.
    J Immunol Methods. 1989 Dec 20;125(1-2):279-85 PMID: 2558138
  32. Detection of circulating tumor necrosis factor after endotoxin administration.
    N Engl J Med. 1988 Jun 9;318(23):1481-6 PMID: 2835680
  33. A novel neutrophil-activating factor produced by human mononuclear phagocytes.
    J Exp Med. 1988 May 1;167(5):1547-59 PMID: 2835419
  34. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.
    J Immunol. 1987 Nov 15;139(10):3474-83 PMID: 2824608
  35. Prevention of pulmonary injury in isolated perfused rat lungs by activated human neutrophils preincubated with anti-Mo1 monoclonal antibody.
    Blood. 1987 Apr;69(4):1167-74 PMID: 3030466
  36. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.
    N Engl J Med. 1988 Aug 18;319(7):397-400 PMID: 3135497
  37. The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate.
    J Exp Med. 1989 Sep 1;170(3):847-63 PMID: 2549166
  38. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions.
    Science. 1989 Dec 22;246(4937):1601-3 PMID: 2688092
  39. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
    J Clin Invest. 1989 Oct;84(4):1045-9 PMID: 2677047
  40. Analysis of human IL-6 mutants expressed in Escherichia coli. Biologic activities are not affected by deletion of amino acids 1-28.
    J Immunol. 1989 Aug 15;143(4):1175-82 PMID: 2663992
  41. Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins.
    Biochem Biophys Res Commun. 1989 Jul 14;162(1):387-93 PMID: 2665743
  42. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.
    J Exp Med. 1989 Mar 1;169(3):823-32 PMID: 2647895
  43. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes.
    Am J Pathol. 1989 Apr;134(4):755-60 PMID: 2650556
  44. The role of activation of neutrophils and microvascular pressure in acute pulmonary edema.
    Am Rev Respir Dis. 1989 Oct;140(4):1052-62 PMID: 2802367
  45. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.
    Am J Med. 1989 Jan;86(1):20-6 PMID: 2783358
  46. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
    J Exp Med. 1989 Jan 1;169(1):333-8 PMID: 2783334
  47. Increased plasma levels of interleukin-6 in sepsis.
    Blood. 1989 Oct;74(5):1704-10 PMID: 2790194
  48. A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity.
    J Exp Med. 1988 Apr 1;167(4):1364-76 PMID: 3258625
  49. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
    J Clin Invest. 1988 Apr;81(4):1162-72 PMID: 3258319
  50. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
    Nature. 1987 Dec 17-23;330(6149):662-4 PMID: 3317066
  51. Activation of coagulation after administration of tumor necrosis factor to normal subjects.
    N Engl J Med. 1990 Jun 7;322(23):1622-7 PMID: 2188129
  52. A C1-inhibitor-complex assay (INCA): a method to detect C1 activation in vitro and in vivo.
    J Immunol. 1981 Oct;127(4):1450-3 PMID: 6168693
  53. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia.
    J Clin Invest. 1981 Nov;68(5):1253-60 PMID: 7298850
  54. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.
    Proc Natl Acad Sci U S A. 1987 Dec;84(24):9233-7 PMID: 3480540
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1992-07-00
Pages
2835-42
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC257242
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com